To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks

Protein therapeutics company Molecular Partners AG (SIX:MOLN) named Patrick Amstutz CEO. Amstutz had been acting CEO since the November 2016 resignation of Christian Zahnd.

Autoimmune and inflammatory disease company Akari Therapeutics plc (NASDAQ:AKTX) said CEO Gur

Read the full 352 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE